Catheter Precision, Inc. — Form 10-Q
Filed August 14, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
David A. Jenkins (CEO) and Philip Anderson (CFO) certified the June 30, 2026 quarterly report on August 14, 2026, per Sarbanes-Oxley Sections 302 and 906. Both officers affirmed that financial statements fairly present the company's condition, that disclosure controls and internal controls over financial reporting are effective, and that no material weaknesses or fraud were identified. No specific operational, financial, or structural changes were disclosed in these certification exhibits.
Why this rating
Routine SOX certifications; no substantive business change reported. Standard periodic compliance filing for micro-cap company.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.